Vodis Pharmaceuticals has been issued both a Standard Cultivation and Standard Processing Licence from Health Canada at its 12,000 sqft indoor facility in Delta, British Columbia.
"The Company is immediately commencing its licensed operation with its acquired well-established and proven, proprietary live cultivars," the team with the company explains. "In addition, we have accumulated an extensive seed collection that will serve as the foundation for future offerings and breeding. Jump-starting with proven, live mother plants significantly shortens the time horizon to bring unique cultivars to the Canadian craft cannabis market."
Further, the company is currently exploring co-packaging options to further accelerate its time to market and revenue.
"We wish to thank our many loyal shareholders and supporters who have stood by the company in the past and presently, and look forward to rewarding that faith as we enter a new phase of the cannabis market and a new era for Vodis."
"Our mission will be to provide the Canadian cannabis consumers with the best cannabis grown by small craft producers which we believe will be the growth area of the Canadian cannabis industry."
For more information:
Vodis Pharmaceuticals
Mark Lotz, Chief Executive Officer and CFO
[email protected]
vodis.ca